STUDYING OF APPLICATION IMMUNOMODULATOR «GALAVIT» AT EXPERIMENTAL ATHEROSCLEROSIS

The changes of the cytokines and lipidic spectrum at experimental hyperlipoidemia and arterial hypertensia was made at 20 rats «Vistar» during 6 months. As the material of research was the blood serum. The cytokines was made by the method solid-phase not competitive immune-enzyme analysis with the u...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: E. P. Turmova, A. A. Grigoryuk, E. A. Bichkov, E. V. Markelova, I. V. Chihkalovets
Formato: article
Lenguaje:RU
Publicado: Scientific Сentre for Family Health and Human Reproduction Problems 2012
Materias:
Q
Acceso en línea:https://doaj.org/article/a2185eadb2a34ae59931885446b9f837
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:a2185eadb2a34ae59931885446b9f837
record_format dspace
spelling oai:doaj.org-article:a2185eadb2a34ae59931885446b9f8372021-11-23T06:14:20ZSTUDYING OF APPLICATION IMMUNOMODULATOR «GALAVIT» AT EXPERIMENTAL ATHEROSCLEROSIS2541-94202587-9596https://doaj.org/article/a2185eadb2a34ae59931885446b9f8372012-05-01T00:00:00Zhttps://www.actabiomedica.ru/jour/article/view/945https://doaj.org/toc/2541-9420https://doaj.org/toc/2587-9596The changes of the cytokines and lipidic spectrum at experimental hyperlipoidemia and arterial hypertensia was made at 20 rats «Vistar» during 6 months. As the material of research was the blood serum. The cytokines was made by the method solid-phase not competitive immune-enzyme analysis with the use of sets: Rat «R&D Diagnostics Inc.», USA. The content of the general cholesterol; triglycerides; LDL; HDL was investigated by the method of standard colorimetric analysis with the use of reagents «Olveks diagnosticum» (Russia). The increasing of the general cholesterol, LDL; HDL, atherogenic coefficient, IFN-γ and IL-1β in blood of animals was revealed. At application of immunomodulator «Galavit» at experimental atherosclerosis the decreasing contains of IL-1, IFN-γ, the level of general cholesterol; LDL; HDL, atherogenic coefficient is fixed.E. P. TurmovaA. A. GrigoryukE. A. BichkovE. V. MarkelovaI. V. ChihkalovetsScientific Сentre for Family Health and Human Reproduction ProblemsarticleatherosclerosishyperlipoidemiacytokinesratsScienceQRUActa Biomedica Scientifica, Vol 0, Iss 3(2), Pp 323-326 (2012)
institution DOAJ
collection DOAJ
language RU
topic atherosclerosis
hyperlipoidemia
cytokines
rats
Science
Q
spellingShingle atherosclerosis
hyperlipoidemia
cytokines
rats
Science
Q
E. P. Turmova
A. A. Grigoryuk
E. A. Bichkov
E. V. Markelova
I. V. Chihkalovets
STUDYING OF APPLICATION IMMUNOMODULATOR «GALAVIT» AT EXPERIMENTAL ATHEROSCLEROSIS
description The changes of the cytokines and lipidic spectrum at experimental hyperlipoidemia and arterial hypertensia was made at 20 rats «Vistar» during 6 months. As the material of research was the blood serum. The cytokines was made by the method solid-phase not competitive immune-enzyme analysis with the use of sets: Rat «R&D Diagnostics Inc.», USA. The content of the general cholesterol; triglycerides; LDL; HDL was investigated by the method of standard colorimetric analysis with the use of reagents «Olveks diagnosticum» (Russia). The increasing of the general cholesterol, LDL; HDL, atherogenic coefficient, IFN-γ and IL-1β in blood of animals was revealed. At application of immunomodulator «Galavit» at experimental atherosclerosis the decreasing contains of IL-1, IFN-γ, the level of general cholesterol; LDL; HDL, atherogenic coefficient is fixed.
format article
author E. P. Turmova
A. A. Grigoryuk
E. A. Bichkov
E. V. Markelova
I. V. Chihkalovets
author_facet E. P. Turmova
A. A. Grigoryuk
E. A. Bichkov
E. V. Markelova
I. V. Chihkalovets
author_sort E. P. Turmova
title STUDYING OF APPLICATION IMMUNOMODULATOR «GALAVIT» AT EXPERIMENTAL ATHEROSCLEROSIS
title_short STUDYING OF APPLICATION IMMUNOMODULATOR «GALAVIT» AT EXPERIMENTAL ATHEROSCLEROSIS
title_full STUDYING OF APPLICATION IMMUNOMODULATOR «GALAVIT» AT EXPERIMENTAL ATHEROSCLEROSIS
title_fullStr STUDYING OF APPLICATION IMMUNOMODULATOR «GALAVIT» AT EXPERIMENTAL ATHEROSCLEROSIS
title_full_unstemmed STUDYING OF APPLICATION IMMUNOMODULATOR «GALAVIT» AT EXPERIMENTAL ATHEROSCLEROSIS
title_sort studying of application immunomodulator «galavit» at experimental atherosclerosis
publisher Scientific Сentre for Family Health and Human Reproduction Problems
publishDate 2012
url https://doaj.org/article/a2185eadb2a34ae59931885446b9f837
work_keys_str_mv AT epturmova studyingofapplicationimmunomodulatorgalavitatexperimentalatherosclerosis
AT aagrigoryuk studyingofapplicationimmunomodulatorgalavitatexperimentalatherosclerosis
AT eabichkov studyingofapplicationimmunomodulatorgalavitatexperimentalatherosclerosis
AT evmarkelova studyingofapplicationimmunomodulatorgalavitatexperimentalatherosclerosis
AT ivchihkalovets studyingofapplicationimmunomodulatorgalavitatexperimentalatherosclerosis
_version_ 1718417268480671744